Recombinant Human PegIFNα2a Protein, GMP Grade
- Specification
- Related Products
| Cat#: |
PegIFNα2a-167THP |
| Common Name: |
PegIFNα2a |
| Product Name: |
Recombinant Human PegIFNα2a Protein, GMP Grade |
| Product Overview: |
Recombinant Human PegIFNα2a Protein without tag was produced in an animal component free process under cGMP guidelines. |
| Species: |
Human |
| Bio-activity: |
180 μg/mL |
| Molecular Mass: |
60000.0 Da |
| AA Sequence: |
CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE |
| Endotoxin: |
<0.001 EU/μg by the LAL method |
| Applications: |
The product is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies. The product is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who havecompensated liver disease and evidence of viral replication and liver inflammation. |
| Usage: |
Compensated liver disease |
| Official Symbol: |
PegIFNα2a |
| Synonyms: |
PegIFNα2a |
Not For Human Consumption!
